JPS5912677B2 - キサンチン誘導体の製法 - Google Patents

キサンチン誘導体の製法

Info

Publication number
JPS5912677B2
JPS5912677B2 JP50010126A JP1012675A JPS5912677B2 JP S5912677 B2 JPS5912677 B2 JP S5912677B2 JP 50010126 A JP50010126 A JP 50010126A JP 1012675 A JP1012675 A JP 1012675A JP S5912677 B2 JPS5912677 B2 JP S5912677B2
Authority
JP
Japan
Prior art keywords
formula
compound
ethylene
compound represented
butylxanthine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP50010126A
Other languages
English (en)
Japanese (ja)
Other versions
JPS50101386A (en:Method
Inventor
ブレンナ− ギユンテル
ゲリング ヨアヒム
アリ カ−ン エスケンダル
ロ−テ オスカ−
タウシエル マンフレツト
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2402908A external-priority patent/DE2402908C2/de
Application filed by Individual filed Critical Individual
Publication of JPS50101386A publication Critical patent/JPS50101386A/ja
Publication of JPS5912677B2 publication Critical patent/JPS5912677B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP50010126A 1974-01-22 1975-01-22 キサンチン誘導体の製法 Expired JPS5912677B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2402908A DE2402908C2 (de) 1974-01-22 1974-01-22 7-(3-Oxobutyl)-1,3-di-(n-butyl)-xanthin und Verfahren zu seiner Herstellung
DE2402908 1974-01-22

Publications (2)

Publication Number Publication Date
JPS50101386A JPS50101386A (en:Method) 1975-08-11
JPS5912677B2 true JPS5912677B2 (ja) 1984-03-24

Family

ID=5905372

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50010126A Expired JPS5912677B2 (ja) 1974-01-22 1975-01-22 キサンチン誘導体の製法

Country Status (13)

Country Link
US (2) US4242345A (en:Method)
JP (1) JPS5912677B2 (en:Method)
AR (1) AR207462A1 (en:Method)
AT (1) AT338286B (en:Method)
BE (1) BE824665A (en:Method)
CA (1) CA1068693A (en:Method)
CH (1) CH608236A5 (en:Method)
FI (2) FI801875A7 (en:Method)
FR (1) FR2258183B1 (en:Method)
GB (1) GB1441562A (en:Method)
HU (1) HU169012B (en:Method)
NL (1) NL184330C (en:Method)
YU (1) YU15175A (en:Method)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2507554A1 (de) * 1975-02-21 1976-09-02 Wuelfing J A Fa 7-(oxoalkyl)-1,3-dialkylxanthine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2507555A1 (de) * 1975-02-21 1976-09-02 Wuelfing J A Fa 7-(oxoalkyl)-1,3-dialkylxanthine, verfahren zu ihrer herstellung und diese verbindung enthaltende arzneimittel
EP0005015B1 (en) * 1978-04-22 1986-10-29 BEECHAM - WUELFING GmbH & Co. KG Use of a xanthine derivate in the manufacture of a medicament
IL59665A0 (en) * 1979-04-05 1980-06-30 Wuelfing J Kg Xanthine derivatives,process for their preparation and their use in pharmaceutical compositions
EP0157098A1 (en) * 1980-06-21 1985-10-09 Beecham Wuelfing GmbH & Co KG Xanthine derivatives, pharmaceuticals compositions containing them and a process for their preparation
GB8418430D0 (en) * 1984-07-19 1984-08-22 Beecham Wuelfing Gmbh & Co Kg Treatment
JPS63225317A (ja) * 1986-10-06 1988-09-20 Hoechst Japan Kk 抗消化性潰瘍剤
US4965271A (en) * 1986-12-31 1990-10-23 Hoechst Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5096906A (en) * 1986-12-31 1992-03-17 University Of Virginia Alumni Patents Foundation Method of inhibiting the activity of leukocyte derived cytokines
JP2661666B2 (ja) * 1988-02-19 1997-10-08 ヘキスト薬品工業株式会社 抗消化性潰瘍剤
GB8826595D0 (en) * 1988-11-14 1988-12-21 Beecham Wuelfing Gmbh & Co Kg Active compounds
US5321029A (en) * 1988-11-14 1994-06-14 Beecham-Wuelfing Gmbh & Co.K.G. Xanthines
CA2030112A1 (en) * 1989-11-24 1991-05-25 Yasuo Ito Xanthine compound, method for preparing thereof, and a pharmaceutical composition comprising the same
ATE138266T1 (de) * 1990-11-07 1996-06-15 Hoechst Roussel Pharma Verwendung von xanthinen zur herstellung von arzneimitteln zur hemmung der vermehrung menschlicher retroviren
US6420374B1 (en) 1990-11-30 2002-07-16 Fred Hutchinson Cancer Research Center Use of xanthines as immunosuppressants and to inhibit allograft reactions
MX9203323A (es) * 1991-07-11 1994-07-29 Hoechst Ag El empleo de derivados de xantina para el tratamiento de lesiones secundarias de las celulas nerviosas y trastornos funcionales despues de traumas craneo-cerebrales.
TW288977B (en:Method) * 1992-02-22 1996-10-21 Hoechst Ag
EP0570831A2 (de) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation
US6448235B1 (en) 1994-07-11 2002-09-10 University Of Virginia Patent Foundation Method for treating restenosis with A2A adenosine receptor agonists
US6514949B1 (en) 1994-07-11 2003-02-04 University Of Virginia Patent Foundation Method compositions for treating the inflammatory response
US6232297B1 (en) * 1999-02-01 2001-05-15 University Of Virginia Patent Foundation Methods and compositions for treating inflammatory response
US7427606B2 (en) * 1999-02-01 2008-09-23 University Of Virginia Patent Foundation Method to reduce inflammatory response in transplanted tissue
US7378400B2 (en) * 1999-02-01 2008-05-27 University Of Virginia Patent Foundation Method to reduce an inflammatory response from arthritis
US6322771B1 (en) 1999-06-18 2001-11-27 University Of Virginia Patent Foundation Induction of pharmacological stress with adenosine receptor agonists
US6670334B2 (en) 2001-01-05 2003-12-30 University Of Virginia Patent Foundation Method and compositions for treating the inflammatory response
WO2003029264A2 (en) * 2001-10-01 2003-04-10 University Of Virginia Patent Foundation 2-propynyl adenosine analogs having a2a agonist activity and compositions thereof
US7442687B2 (en) * 2004-08-02 2008-10-28 The University Of Virginia Patent Foundation 2-polycyclic propynyl adenosine analogs having A2A agonist activity
CA2576826C (en) * 2004-08-02 2014-09-30 University Of Virginia Patent Foundation 2-propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity
US7576069B2 (en) * 2004-08-02 2009-08-18 University Of Virginia Patent Foundation 2-polycyclic propynyl adenosine analogs having A2A agonist activity
US8178509B2 (en) * 2006-02-10 2012-05-15 University Of Virginia Patent Foundation Method to treat sickle cell disease
US8188063B2 (en) 2006-06-19 2012-05-29 University Of Virginia Patent Foundation Use of adenosine A2A modulators to treat spinal cord injury
US8058259B2 (en) 2007-12-20 2011-11-15 University Of Virginia Patent Foundation Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2756229A (en) * 1956-07-24 Xanthine derivatives
CA557342A (en) 1958-05-13 Doebel Karl Process for the manufacture of novel xanthine derivatives
US2761863A (en) * 1956-09-04 Lower-alkyl
FR4791E (fr) 1900-06-29 1905-10-16 Eugene Fournier Lampe à pétrole perfectionnée pour chauffage intensif dite: "la naphteuse"
DE926788C (de) 1952-11-07 1955-04-25 Geigy Ag J R Verfahren zur Herstellung von 1, 3-dialkylierten 7-Oxyalkyl-xanthinabkoemmlingen
GB759174A (en) * 1952-11-07 1956-10-17 Geigy Ag J R Improvements in diuretic acting xanthine derivatives
GB759981A (en) * 1953-09-09 1956-10-24 Roche Products Ltd Process for the manufacture of xanthine derivatives
CH325292A (de) 1953-10-21 1957-10-31 Geigy Ag J R Verfahren zur Herstellung von 7-Oxyalkyl-xanthinderivaten
US3737433A (en) * 1964-09-05 1973-06-05 Albert Ag Chem Werke Certain oxoalkyldimethylxanthines
DE2234202A1 (de) 1972-07-12 1974-01-24 Albert Ag Chem Werke Verfahren zur herstellung von oxoalkylxanthinen
DE2330742C2 (de) * 1973-06-16 1982-07-29 Hoechst Ag, 6000 Frankfurt 1-(Oxoalkyl)-3-methyl-7-alkylxanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2457666A1 (de) * 1974-12-06 1976-06-10 Hoechst Ag Arzneimittel, verfahren zur herstellung von dafuer geeigneten wirkstoffen und diese oxoalkyl-dialkyl-xanthine
JPS5233120A (en) * 1975-09-10 1977-03-14 Nisshin Steel Co Ltd Double coiled automobile steel pipe covered with heat flexible plastic resin

Also Published As

Publication number Publication date
US4242345A (en) 1980-12-30
HU169012B (en:Method) 1976-08-28
YU15175A (en) 1982-06-30
ATA929674A (de) 1976-12-15
NL184330B (nl) 1989-01-16
JPS50101386A (en:Method) 1975-08-11
FR2258183B1 (en:Method) 1978-07-28
GB1441562A (en) 1976-07-07
FI801875A7 (fi) 1981-01-01
FI59596C (fi) 1981-09-10
US4291037A (en) 1981-09-22
AT338286B (de) 1977-08-10
AR207462A1 (es) 1976-10-08
CH608236A5 (en:Method) 1978-12-29
FI750122A7 (en:Method) 1975-07-23
NL184330C (nl) 1989-06-16
NL7414887A (nl) 1975-07-24
FI59596B (fi) 1981-05-29
BE824665A (fr) 1975-05-15
FR2258183A1 (en:Method) 1975-08-18
CA1068693A (en) 1979-12-25

Similar Documents

Publication Publication Date Title
JPS5912677B2 (ja) キサンチン誘導体の製法
SU1396963A3 (ru) Способ получени производных дигидропиридазинона
US4804664A (en) Method and pharmaceutical preparation for treating chronic obstructive airway disease and cardiac disease, and intermediates for the preparation of therapeutically active xanthine derivatives
US4514568A (en) 5-(4-Nitrophenyl)-2(1H)-pyrazinones
CA1048535A (en) 1,3-diphenyl-propanone-1-derivatives and the salts thereof and sweetening agents containing same
BE1000573A4 (fr) Derives de 1-(hydroxystyryl)-5h-2,3-benzodiazepine, procede pour les preparer et compositions pharmaceutiques les contenant.
KR860001865B1 (ko) 2'-데옥시-5-치환 우리딘 유도체의 제조방법
Takeshita et al. Effects of propranolol on baroreflex sensitivity in borderline hypertension
US3201459A (en) Guanidine
JPS59176279A (ja) ６−〔（置換）−１ｈ−イミダゾ−ル−４−イルまたは５−イル〕−３（２ｈ）−ピリダジノン化合物
DE3851720D1 (de) Indolylpropanole, Verfahren zu ihrer Herstellung und ihre Verwendung sowie die Verbindungen enthaltende Zubereitungen.
SU1342416A3 (ru) Способ получени производных пиридазинона или их водорастворимых солей с фармацевтически приемлемой кислотой
IL120997A (en) Pharmaceutical preparations containing a history of xanthine are converted into positions 1 and 3 for the treatment and prevention of shock conditions, a number of such new compounds, and a process for their preparation.
HU181944B (en) Process for preparing /+/-/3alpha,16alpha/-14-imino-/15h/-eburnamenine
US5215987A (en) Substituted benzhydryl 2-hydroxypropyl piperazine derivatives
SU852173A3 (ru) Способ получени производных дигидРОиМидАзО изОХиНО-лиНА или иХ СОлЕй
EP0430025A2 (en) Xanthine compound, method for preparing thereof, and a pharmaceutical composition comprising the same
US4421754A (en) Syndonimine derivatives, process for production thereof, and use thereof
PL96042B1 (pl) Sposob wytwarzania nowych aminopochodnych azydofenoli
PL93702B1 (en) Fused-ring isoquinoline derivatives[gb1438819a]
KR850000210B1 (ko) 옥사졸린의 제조방법
JPS58225041A (ja) 新規カルバシクリンエステル、その製法及び該エステルを含有する降圧作用を有する医薬
US4416875A (en) Ester derivatives of deoxyfluorouridine
US3079402A (en) Cero-chromonamino compounds
NO143706B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-alkyl-7-(omega-1)-oksoalkylxantiner